Ignite Creation Date:
2025-12-25 @ 2:16 AM
Ignite Modification Date:
2025-12-26 @ 12:46 AM
Study NCT ID:
NCT00226460
Status:
COMPLETED
Last Update Posted:
2015-03-18
First Post:
2005-09-23
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Phase 2, Double-blind, Randomized, Controlled Multi-center Clinical Trial of the Safety and Efficacy of Transplanted Fetal Porcine Cells in Patients With Parkinson's Disease.
Sponsor:
Genzyme, a Sanofi Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
1997-08
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
2001-01
Completion Date Type:
None
First Submit Date:
2005-09-23
First Submit QC Date:
None
Study First Post Date:
2005-09-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-03-17
Last Update Post Date:
2015-03-18
Last Update Post Date Type:
ESTIMATED